# Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus

> **NCT00789750** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 562 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Colesevelam
- **DRUG:** Placebo
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00789750
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 562 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789750, "Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00789750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*